MLTX,MoonLake Immunotherapeutics | Healthcare

Healthcare

MLTX

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

MoonLake ImmunotherapeuticsMLTX

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies.

It is developing Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases.

The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or axial spondyloarthritis.

MoonLake Immunotherapeutics was incorporated in 2021 and is headquartered in Zug, Switzerland.

Latest News >

Ex-Japan PM Shinzo Abe dead: A look at top world leaders who were assassinated

Jul 8, 2022

Former Japanese prime minister Shinzo Abe was shot and killed on July 8, while he was campaigning for a parliamentary election in Nara region. As the world mourns Abe's death, here is a look at some of the top political assassinations.

Theranos COO Ramesh Balwani found guilty of multimillion-dollar fraud in US

Jul 8, 2022

Blood testing company Theranos' Chief Operating Officer Ramesh 'Sunny' Balwani has been found guilty by a federal jury in the US on all counts he was charged with related to a multimillion-dollar fraud scheme at the company founded by his former girlfriend Elizabeth Holmes, once touted as Silicon Valley's rising star

ENG vs IND 1st T20I: Hardik Pandya's all-round show steers India to 50-run over England

Jul 8, 2022

Pandya became only the fourth player from full member nations to score a fifty and take four wickets in a T20I match. The swashbuckling all-rounder first led India aggressive charge in batting with a blistering 33-ball 51, that propelled the the visitors to 198 for eight after they opted to bat first. Pandya then finished with excellent figures of 4/33, destroying England's batting with his full quota of four overs.

Wimbledon 2022: Abdominal strain forces Nadal to pull out of semifinal against Kyrgios

Jul 8, 2022

With the Spaniard's withdrawal, unseeded 27-year-old Kyrgios became the first Australian to reach the men's singles final at the All England Club since Mark Philippoussis in 2003.